REX AMERICAN RESOURCES CORPORATION (REX) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2025-07-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2025-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2025-07-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2025-07-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 650.01M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-07-31 | (m) | $650.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-04-30 | (m) | $466.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-10-31 | (m) | $439.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-07-31 | (m) | $433.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-04-30 | (m) | $431.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-01-31 | (m) | $572.23M | (m) | (m) | $2.07M | (m) | (m) | (m) | Reported |
| 2014-10-31 | (m) | $590.71M | (m) | (m) | $2.60M | (m) | (m) | (m) | Reported |
| 2014-07-31 | (m) | $618.45M | (m) | (m) | $3.10M | (m) | (m) | (m) | Reported |
| 2014-04-30 | (m) | $643.60M | (m) | (m) | $3.54M | (m) | (m) | (m) | Reported |
| 2014-01-31 | (m) | $666.09M | (m) | (m) | $3.90M | (m) | (m) | (m) | Reported |
| 2013-10-31 | (m) | $695.69M | (m) | (m) | $4.22M | (m) | (m) | (m) | Reported |
| 2013-07-31 | (m) | $708.03M | (m) | (m) | $4.45M | (m) | (m) | (m) | Reported |
| 2013-04-30 | (m) | $685.48M | (m) | (m) | $4.65M | (m) | (m) | (m) | Reported |
| 2013-01-31 | (m) | $657.74M | (m) | (m) | $4.87M | (m) | (m) | (m) | Reported |
| 2012-10-31 | (m) | $653.59M | (m) | (m) | $5.29M | (m) | (m) | (m) | Reported |
| 2012-07-31 | (m) | $559.17M | (m) | (m) | $4.71M | (m) | (m) | (m) | Reported |
| 2012-04-30 | (m) | $479.80M | (m) | (m) | $4.10M | (m) | (m) | (m) | Reported |
| 2012-01-31 | (m) | $409.95M | (m) | (m) | $3.48M | (m) | (m) | (m) | Reported |
| 2011-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-01-31 | (m) | $301.41M | (m) | (m) | $5.56M | (m) | (m) | (m) | Reported |
| 2010-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-01-31 | (m) | $169.78M | $234.00K | (m) | $4.72M | (m) | 0.14% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Green Plains Inc. (GPRE) | United States | $1.054B | 8.70 |
| Westlake Chemical Partners LP (WLKP) | United States | $0.754B | 2.35 |
| Gevo, Inc. (GEVO) | United States | $0.345B | -1.72 |
| Alto Ingredients, Inc. (ALTO) | United States | $0.289B | 8.52 |
| FutureFuel Corp. (FF) | United States | $0.225B | -6.53 |
| Comstock Inc. (LODE) | United States | $0.195B | -5.19 |
| XCF Global, Inc. (SAFX) | United States | $0.171B | -2.86 |
| CODEXIS, INC. (CDXS) | United States | $0.151B | -6.68 |
| AEMETIS, INC (AMTX) | United States | $0.128B | -1.95 |
| LanzaTech Global, Inc. (LNZA) | United States | $0.078B | 0.52 |